Home > Community Information > Archives > All Archived Articles > Wisconsin Alumni Research... 
Wisconsin Alumni Research Foundation changes stem cell policies to encourage greater academic, industry collaboration
(Madison, WI) The Wisconsin Alumni Research Foundation (WARF) announced today three policy changes and clarifications that are expected to have a positive effect on stem cell research. The new policies will affect industry-sponsored stem cell research, academic and commercial licensing, and WARF’s relationship with the California Institute for Regenerative Medicine (CIRM), and will apply to current and future license agreements.

Industry-sponsored stem cell research will be facilitated by a new WARF policy that will enable companies to sponsor research at an academic or non-profit institution without a license, regardless of location and regardless of intellectual property rights passing from the research institution to the company. This will enable companies to get started with stem cell research in a low-cost, visible manner and increase funding of stem cell research by for-profit companies. Companies will still need a license when they want to bring the research into their company laboratories or when they want to develop a product for the market.

Second, while ensuring provisions related to informed consent for embryo donations are communicated and honored, WARF is changing the cell transfer provisions in its academic and commercial licensing. The new policy will allow easier and simpler, cost-free cell transfers among researchers. This will facilitate collaborations within the human embryonic stem cell research community and thus advance the field.

WARF is also clarifying its position with regards to the California Institute for Regenerative Medicine (CIRM). As a not-for-profit, grant-making organization, CIRM does not require any license or agreement from WARF to pursue its grant making policies. Further, WARF does not expect CIRM to remit to WARF or WiCell any portion of payment that CIRM receives from its grantees. WARF has been and will continue to be supportive of CIRM’s efforts to fund human embryonic stem cell research and move the technology forward.

The WARF policy changes are effective immediately. Documents reflecting these changes are now available on the WiCell and NIH Web sites (http://www.wicell.org and http://stemcells.nih.gov/research/registry, respectively.)
CONTACT:    Andy Cohn<> Director of Government Relations and Public Relations, Wisconsin Alumni Research Foundation (608) 263-2821
Printer Friendly Version